Literature DB >> 32632018

Adiponectin and related C1q/TNF-related proteins bind selectively to anionic phospholipids and sphingolipids.

Jessica J Ye1,2, Xin Bian3,4, Jaechul Lim1,2, Ruslan Medzhitov5,2.   

Abstract

Adiponectin (Acrp30) is an adipokine associated with protection from cardiovascular disease, insulin resistance, and inflammation. Although its effects are conventionally attributed to binding Adipor1/2 and T-cadherin, its abundance in circulation, role in ceramide metabolism, and homology to C1q suggest an overlooked role as a lipid-binding protein, possibly generalizable to other C1q/TNF-related proteins (CTRPs) and C1q family members. To investigate this, adiponectin, representative family members, and variants were expressed in Expi293 cells and tested for binding to lipids in liposomes using density centrifugation. Binding to physiological lipids were also analyzed using gradient ultracentrifugation, liquid chromatography-mass spectrometry, and shotgun lipidomics. Interestingly, adiponectin selectively bound several anionic phospholipids and sphingolipids, including phosphatidylserine, ceramide-1-phosphate, glucosylceramide, and sulfatide, via the C1q domain in an oligomerization-dependent fashion. Binding to lipids was observed in liposomes, low-density lipoproteins, cell membranes, and plasma. Other CTRPs and C1q family members (Cbln1, CTRP1, CTRP5, and CTRP13) also bound similar lipids. These findings suggest that adiponectin and CTRPs function not only as hormones, but also as lipid opsonins, as may other C1q family proteins.

Entities:  

Keywords:  adipokine; adiponectin; lipid binding; opsonin

Mesh:

Substances:

Year:  2020        PMID: 32632018      PMCID: PMC7382265          DOI: 10.1073/pnas.1922270117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  65 in total

1.  XCMS Online: a web-based platform to process untargeted metabolomic data.

Authors:  Ralf Tautenhahn; Gary J Patti; Duane Rinehart; Gary Siuzdak
Journal:  Anal Chem       Date:  2012-05-10       Impact factor: 6.986

2.  Factor H binds to the N-terminus of adiponectin and modulates complement activation.

Authors:  Philip Peake; Yvonne Shen
Journal:  Biochem Biophys Res Commun       Date:  2010-06-01       Impact factor: 3.575

3.  Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.

Authors:  Yukihiro Takemura; Noriyuki Ouchi; Rei Shibata; Tamar Aprahamian; Michael T Kirber; Ross S Summer; Shinji Kihara; Kenneth Walsh
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 4.  Synapse organization and modulation via C1q family proteins and their receptors in the central nervous system.

Authors:  Keiko Matsuda
Journal:  Neurosci Res       Date:  2016-11-12       Impact factor: 3.304

5.  The complete complement of C1q-domain-containing proteins in Homo sapiens.

Authors:  Y Tom Tang; Tianhua Hu; Matthew Arterburn; Bryan Boyle; Jessica M Bright; Servando Palencia; Peter C Emtage; Walter D Funk
Journal:  Genomics       Date:  2005-04-18       Impact factor: 5.736

6.  Loss of CTRP1 disrupts glucose and lipid homeostasis.

Authors:  Susana Rodriguez; Xia Lei; Pia S Petersen; Stefanie Y Tan; Hannah C Little; G William Wong
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-08-23       Impact factor: 4.310

7.  Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis.

Authors:  Jonathan Y Xia; William L Holland; Christine M Kusminski; Kai Sun; Ankit X Sharma; Mackenzie J Pearson; Angelika J Sifuentes; Jeffrey G McDonald; Ruth Gordillo; Philipp E Scherer
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

Review 8.  Overnutrition, ectopic lipid and the metabolic syndrome.

Authors:  Scott M Grundy
Journal:  J Investig Med       Date:  2016-05-18       Impact factor: 2.895

9.  A family of Acrp30/adiponectin structural and functional paralogs.

Authors:  Guang W Wong; Jin Wang; Christopher Hug; Tsu-Shuen Tsao; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

10.  Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers.

Authors:  Rebecca L Shaner; Jeremy C Allegood; Hyejung Park; Elaine Wang; Samuel Kelly; Christopher A Haynes; M Cameron Sullards; Alfred H Merrill
Journal:  J Lipid Res       Date:  2008-11-25       Impact factor: 5.922

View more
  6 in total

Review 1.  CTRP family in diseases associated with inflammation and metabolism: molecular mechanisms and clinical implication.

Authors:  Huan Zhang; Zi-Yin Zhang-Sun; Cheng-Xu Xue; Xi-Yang Li; Jun Ren; Yu-Ting Jiang; Tong Liu; Hai-Rong Yao; Juan Zhang; Tian-Tian Gou; Ye Tian; Wang-Rui Lei; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2022-10-07       Impact factor: 7.169

2.  Remodeling glycerophospholipids affects obesity-related insulin signaling in skeletal muscle.

Authors:  Michael J Wolfgang
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

Review 3.  The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.

Authors:  Bianca C Field; Ruth Gordillo; Philipp E Scherer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-02       Impact factor: 5.555

Review 4.  Paradigm shift: the primary function of the "Adiponectin Receptors" is to regulate cell membrane composition.

Authors:  Marc Pilon
Journal:  Lipids Health Dis       Date:  2021-04-30       Impact factor: 3.876

5.  Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects.

Authors:  Raneem Khedraki; Hirotsugu Noguchi; William M Baldwin
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 8.786

Review 6.  Adiponectin in psoriasis and its comorbidities: a review.

Authors:  Bai Ruiyang; Fu Siqi; Adriana Panayi; Wu Ruifang; Zhang Peng
Journal:  Lipids Health Dis       Date:  2021-08-09       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.